In addition, many studies have confirmed that miR-155 upregulation may directly contribute to chemotherapy resistance to 5-FU and Cisplatin among oral cancers through additional pathway modulation, such as TP53INP1 [70,71,72]. The gene discussed is TP53INP1; the disease is lip and oral cavity carcinoma.